Optimum Therapeutics, LLC
1 clinical trials · Sponsor
◉ Watch Optimum Therapeutics, LLC
| Record | Firm | Date |
|---|---|---|
| Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer (NCT01038752) | Optimum Therapeutics, LLC | 2010-08-01 |
Track Optimum Therapeutics, LLC automatically
Every clearance here is in the API, with alerts when new ones post.